These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 105250)

  • 41. [Digestive insufficiency and its treatment with a new three-phase enzyme drug].
    Krueger GA
    Landarzt; 1968 Aug; 44(24):1156-61. PubMed ID: 4236296
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical comparison of Dactil and Dactilase in digestive disorders].
    Plancherel P
    Praxis; 1969 Oct; 58(40):1275-8. PubMed ID: 5394572
    [No Abstract]   [Full Text] [Related]  

  • 43. Replacement therapy in pancreatic insufficiency with a new pancreatin preparation respecting the physiological ratio of lipase/trypsin activity.
    Pap A; Varró V
    Hepatogastroenterology; 1988 Apr; 35(2):83-6. PubMed ID: 3371850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ins and outs of pancreatic enzymes and adjuvant therapies.
    Graham DY
    J Pediatr Gastroenterol Nutr; 1984; 3 Suppl 1():S120-6. PubMed ID: 6568276
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Local application of several enzymes in the treatment of chronic suppurative otitis media with cholesteatoma].
    Feĭgin GA; Tikhomirova NN; Volodkevich SM; Egorov VI
    Vestn Otorinolaringol; 1970 May; 32(3):26-30. PubMed ID: 4915630
    [No Abstract]   [Full Text] [Related]  

  • 47. [Enzyme substitution in chronic pancreatitis].
    Papp J; Leuthold E; Ammann R
    Praxis; 1969 Nov; 58(44):1428-31. PubMed ID: 5395674
    [No Abstract]   [Full Text] [Related]  

  • 48. Steatorrhea and azotorrhea and their relation to growth and nutrition in adolescents and young adults with cystic fibrosis.
    Lapey A; Kattwinkel J; Di Sant'Agnese PA; Laster L
    J Pediatr; 1974 Mar; 84(3):328-34. PubMed ID: 4811984
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of exogenous pancreatic enzymes on gastrointestinal and pancreatic hormone release and gastrointestinal motility.
    Malfertheiner P; Domínguez-Muñoz JE
    Digestion; 1993; 54 Suppl 2():15-20. PubMed ID: 8224568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis.
    Brady MS; Rickard K; Yu PL; Eigen H
    J Am Diet Assoc; 1992 Jul; 92(7):813-7. PubMed ID: 1624649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fecal fat concentration in the differential diagnosis of steatorrhea.
    Bai JC; Andrüsh A; Matelo G; Martinez C; Vazquez H; Boerr L; Sambuelli A
    Am J Gastroenterol; 1989 Jan; 84(1):27-30. PubMed ID: 2912027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correction of malnutrition and maldigestion with enzyme supplementation in patients with surgical suppression of exocrine pancreatic function.
    Braga M; Cristallo M; De Franchis R; Mangiagalli A; Agape D; Primignani M; Di Carlo V
    Surg Gynecol Obstet; 1988 Dec; 167(6):485-92. PubMed ID: 3187872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The treatment of gastrointestinal disorders with Enzymed].
    Heide M
    Hippokrates; 1968 Aug; 39(16):636-7. PubMed ID: 4883271
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical efficacy test of a digestive enzyme preparation--a blind study].
    Tomasi A; Ghidini O; Battocchia A
    Med Welt; 1972 Nov; 23(47):1779-80. PubMed ID: 4678437
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparative double blind experience of a polyenzymatic preparation in chronic pancreatic insufficiency (author's transl)].
    Knill-Jones RP; Batten PJ; Williams R
    Acta Gastroenterol Belg; 1973 Sep; 36(9):489-504. PubMed ID: 4589486
    [No Abstract]   [Full Text] [Related]  

  • 57. [Substantiation of enterosane application for the treatment of celiac disease].
    Bogdarin IuA; Repin AA
    Eksp Klin Gastroenterol; 2004; (4):36-8. PubMed ID: 15568666
    [No Abstract]   [Full Text] [Related]  

  • 58. [Dysfunction of digestion].
    ALEXEJEW M
    Ther Ggw; 1958 Mar; 97(3):108-9. PubMed ID: 13543811
    [No Abstract]   [Full Text] [Related]  

  • 59. Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue.
    Gass J; Bethune MT; Siegel M; Spencer A; Khosla C
    Gastroenterology; 2007 Aug; 133(2):472-80. PubMed ID: 17681168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Raised fecal fat concentration is not a valid indicator of pancreatic steatorrhea.
    Lembcke B; Grimm K; Lankisch PG
    Am J Gastroenterol; 1987 Jun; 82(6):526-31. PubMed ID: 3646827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.